Outset Medical, Inc. revenue by segment OM

Outset Medical, Inc. splits its revenue into 3 lines in its filings. The largest line in Q3 of fiscal 2026, the quarter ended Sep 30, 2026 was Consumables Product at $13.2 million, 39% of the total.

USD in millions. The percent under a figure is the change from the same quarter a year earlier.

Line
TTM
Sep 30, 2026
Q3 FY2026
Sep 30, 2026
Q2 FY2026
Jun 30, 2026
Q1 FY2026
Mar 31, 2026
Q4 FY2025
Dec 31, 2025
Q3 FY2025
Sep 30, 2025
Q2 FY2025
Jun 30, 2025
Q1 FY2025
Mar 31, 2025
Q4 FY2024
Dec 31, 2024
Revenue
122
34
32
28
29
29
31
30
29
Consumables Product
52
-6.3%
share 42.9%
13
+8.2%
share 39.4%
12
-12.2%
share 39.3%
13
-7.2%
share 47.3%
14
-11.5%
share 46.8%
12
share 41.5%
14
share 45.0%
14
share 47.7%
15
share 51.8%
Consoles Product
32
+5.3%
share 26.0%
10
+25.6%
share 31.2%
9
+6.2%
share 30.0%
5
-24.2%
share 19.3%
6
+10.8%
share 22.1%
8
share 28.3%
9
share 28.4%
7
share 23.8%
6
share 19.5%
Service And Other Revenue
38
+11.2%
share 31.1%
10
+11.6%
share 29.5%
10
+16.7%
share 30.7%
9
+10.1%
share 33.4%
9
+6.4%
share 31.2%
9
share 30.1%
8
share 26.5%
8
share 28.4%
8
share 28.7%
How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.

Company profile

Industry
Electromedical & Electrotherapeutic Apparatus (SIC 3845)
Listed as
OM (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
San Jose, CA
SEC filer status
Accelerated filer, Smaller reporting company
SEC CIK
1484612
Former names
Home Dialysis Plus, Ltd. (until Feb 25, 2011)

Other Electromedical & Electrotherapeutic Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.